Table 4.

Treatment and follow-up

HAART initiation in patients with HIV, n=1010 (100%)
Steroids, n=2310 (43%)
RAS inhibitors, n=2311 (48%)
Cyclosporin, n=232 (9%)
Mean follow-up, mo, n=2323 (range, 0.5–220)
Complete remission of nephrotic syndrome, n=22/234 (18%)
Kidney status at last follow-up, n=23a
 Hemodialysis6 (27%)
 Kidney transplant2 (9%)
 Mean eGFR at last follow-up visit in those not needing KRT, ml/min per 1.73 m2, n=1551 (range, 9.5–113)
  • HAART, highly active antiretroviral therapy; RAS, renin-angiotensin system.

  • a Death occurred in one patient 1 month after kidney biopsy.